Product
Olmesartan Medoxomil + Chlorthalidone
Aliases
Olmesartan Medoxomil 20mg + Chlorthalidone 12,5mg, Olmesartan medoxomil 40mg + chlorthalidone 25mg
2 clinical trials
2 indications
Indication
Essential hypertensionIndication
HypertensionClinical trial
Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan + Chlorthalidone, Produced by EMS S.A,in Arterial Hypertension ControlStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Efficacy and Safety Evaluation of the New Association on Fixed Dose of Olmesartan Medoxomil + Chlorthalidone (40mg + 12.5mg and 40mg + 25mg) Compared With BENICAR HCT® in Hypertension ControlStatus: Not yet recruiting, Estimated PCD: 2025-06-01